A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in several kinds of malignancies, https://bookmarkingdepot.com/story21871337/nanobodies-restore-tumor-suppressor-p53-a-promising-hope-for-malignant-management